Evidence map›Paper›PMID 32247767›Full record

ArticleToxicology and applied pharmacology2020

Corrigendum to "A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm" [Toxicology and Applied Pharmacology volume 394C (2020) 114961].

Bradley J Ridder, Derek J Leishman, Matthew Bridgland-Taylor, Mohammadreza Samieegohar, Xiaomei Han, Wendy W Wu, Aaron Randolph, Phu Tran, Jiansong Sheng, Timm Danker and 33 more

Abstract readPublished Erratum
In one paragraph

Article in Toxicology and applied pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors.

Bradley J RidderDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.
Derek J LeishmanDepartment of Toxicology and Pathology, Eli Lilly and Company, Indianapolis, IN, USA.
Matthew Bridgland-TaylorClinical Pharmacology & Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Mohammadreza SamieegoharDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.
Xiaomei HanDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.
Wendy W WuDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.
Aaron RandolphDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.
Phu TranDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.
Jiansong ShengCiPA LAB, 900 Clopper Rd, Suite 130, Gaithersburg, MD 20878, USA.
Timm DankerNMI-TT GmbH, Markwiesenstr. 55, 72770 Reutlingen, Germany.
Anders LindqvistSophion Bioscience A/S, Baltorpvej 154, 2750 Ballerup, Denmark.
Daniel KonradB'SYS GmbH, The Ion Channel Company, Benkenstrasse 254, CH-4108 Witterswil, Switzerland.
Simon HebeisenB'SYS GmbH, The Ion Channel Company, Benkenstrasse 254, CH-4108 Witterswil, Switzerland.
Liudmila PolonchukF. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd., Bldg. 73 / R. 103b Grenzacherstrasse, 124, CH-4070, Basel, Switzerland.
Evgenia GissingerF. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd., Bldg. 73 / R. 103b Grenzacherstrasse, 124, CH-4070, Basel, Switzerland.
Muthukrishnan RenganathanEurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.
Bryan KociEurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.
Haiyang WeiEurofins Scientific, Eurofins Discovery, 6 Research Park Drive, St. Charles, MO 63304, USA.
Jingsong FanBristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.
Paul LevesqueBristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.
Jae KwaghBristol-Myers Squibb Company, Discovery Toxicology, Bristol-Myers Squibb, 3551 Lawrenceville, Princeton Rd, Lawrence Township, NJ 08648, USA.
John ImredyMerck & Co., Inc., Kenilworth, NJ, USA.
Jin ZhaiMerck & Co., Inc., Kenilworth, NJ, USA.
Marc RogersMetrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21 6AD, United Kingdom.
Edward HumphriesMetrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21 6AD, United Kingdom.
Robert KirbyMetrion Biosciences Limited, Riverside 3, Suite 1, Granta Park, Great Abington, Cambridge CB21 6AD, United Kingdom.
Sonja Stoelzle-FeixNanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.
Nina BrinkwirthNanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.
Maria Giustina RotordamNanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.
Nadine BeckerNanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.
Søren FriisNanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.
Markus RapediusNanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.
Tom A GoetzeNanion Technologies Munich, Ganghoferstrasse 70A, 80339 Munich, Germany.
Tim StrassmaierNanion Technologies USA, 1 Naylon Place, Suite C, Livingston, NJ 07039, USA.
George OkeyoNanion Technologies USA, 1 Naylon Place, Suite C, Livingston, NJ 07039, USA.
James KramerCharles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.
Yuri KuryshevCharles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.
Caiyun WuCharles River Laboratories, 14656 Neo Parkway, Cleveland, OH 44128, USA.
Herbert HimmelBayer AG, RD-TS-TOX-SP-SPL1, Aprather Weg 18a, 42096 Wuppertal, Germany.
Gary R MiramsCentre for Mathematical Medicine & Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, United Kingdom.
David G StraussDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA.
Remi BardenetUniversité de Lille, CNRS, Centrale Lille, UMR 9189 - CRIStAL, Villeneuve d'Ascq, France.
Zhihua LiDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. Electronic address: Zhihua.li@fda.hhs.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32247767
PMCPMC7355225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.